Find a provider to order the Autoimmune Brain Panel™
Looking beneath the surface to bring you answers.
Still struggling with symptoms like anxiety, depression, OCD, tics or mood changes — despite treatment? The Autoimmune Brain Panel™ may provide some answers. This advanced blood test can help identify whether your symptoms may be due to an underlying immune dysfunction, triggered by infection – rather than a primary neurologic or psychiatric disorder.
One simple blood draw – ordered by your provider – may put you on the path to recovery.
Don’t have a provider? Let us help you find one.
Are you looking for a clinician to order the Autoimmune Brain Panel™? We can help!
Please complete this form and our Medical Relations Manager, Amy Cross, RN PMHNP, will be in touch to provide several options.
Live in New York? International?
The Autoimmune Brain Panel™ requires a clinician order before we can receive and process any specimen. Moleculera Biosciences can accept clinician test orders from all 50 states in the U.S. and other countries. Practitioners in New York State may order the Autoimmune Brain Panel™ but specimens must be collected at a facility outside the State of New York.
Patients living outside the United States, can order the test through one of our international partners. Please visit our international ordering page.
We understand advanced testing can feel out of reach. That’s why we offer flexible payment plans and accept all major credit cards to make access easier. The total cost for the Autoimmune Brain Panel™ is $995 in the U.S. However, approximately 50% of our patients receive some level of reimbursement from their insurance company. While Moleculera does not accept insurance, we will file a claim on your behalf, as a courtesy.
The Autoimmune Brain Panel™ requires a clinician order before we can receive and process any specimen. Moleculera Biosciences can accept clinician test orders from all 50 states in the U.S. and other countries. Practitioners in New York State may order the Autoimmune Brain Panel™ but specimens must be collected at a facility outside the State of New York. Patients residing outside the U.S., please see our International Ordering Page.
- In the continental United States, the cost for the Panel is $995.
- In Alaska, Hawaii, and Canada, the cost for the Panel is $1070 (USD).
- Payment plans are available.
- We accept checks, credit cards, FSA and HSA.
The Autoimmune Brain Panel™ is designed to help uncover whether neuropsychiatric symptoms are being driven by an infection-triggered autoimmune response rather than a primary psychiatric or neurological disorder.
Identifying an autoimmune component is important, since it typically changes the course of treatment to focus on the underlying infections and immune dysfunction, rather than solely treating with psychotropic medications.
Once these conditions are properly identified and treated, many patients report dramatic improvement — ranging from significant symptom reduction to complete resolution.
Neuropsychiatric Symptoms and Test Biomarkers
Anti-Dopamine D1 Receptor Antibodies
Individuals with elevated levels of autoantibodies against Dopamine D1 receptor typically experienced psychiatric symptoms, including psychosis.
Anti-Dopamine D2 Receptor Antibodies
Individuals with elevated levels of autoantibodies against Dopamine D2 receptor typically experienced movement disorders and impulsivity.
Anti-Lysoganglioside GM1 Antibodies
Individuals with elevated levels of autoantibodies against Lysoganglioside GM1 typically experienced neuropathic symptoms, including tics.
Anti-Tubulin Antibodies
Individuals with elevated levels of autoantibodies against Tubulin typically experienced cognitive complaints, OCD and brain fog.
CaMKII – A Cell Stimulation Assay
Individuals with elevated CaMKII levels were often positive with involuntary movements and any symptom of adrenergic activation.
An elevated CaMKII result indicates a patient’s autoantibodies are stimulating this enzyme. CaMKII is responsible for upregulating brain neurotransmitters such as dopamine, epinephrine and norepinephrine.
CaMKII activation may result in disrupted neuronal functioning, and trigger a variety of neurologic and/or psychiatric symptoms.